Proscia Launches AI-Powered Digital Pathology Solution

Published on: 

Applied Clinical Trials

Proscia has released DermAI, a module on Proscia’s Concentriq Platform that leverages deep learning to pre-screen and classify skin biopsies. Proscia intends to submit DermAI to the FDA for review to use in clinical diagnosis.

To learn more, click here.